Section:
Bilateral Contracts and Grants with Industry
Bilateral Contracts with Industry
Roche Institute, through the Vaccine Research Institute,
funding one engineer over 2 years (2012-2014)
Cytheris (now RevImmune), through the ANRS, for the
development of IL-7, as this is the only one company able to
produce exogeneous IL-7 usable in Humans.